Max More

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Max More at the 2006 Stanford Singularity Summit.

Max More (born Max T. O'Connor, January 1964) is a philosopher and futurist who writes, speaks, and consults on advanced decision-making about emerging technologies.[1][2]

Born in Bristol, England, More has a degree in Philosophy, Politics and Economics from St Anne's College, Oxford (1987).[3][4] His 1995 University of Southern California doctoral dissertation "The Diachronic Self: Identity, Continuity, and Transformation" examined several issues that concern transhumanists, including the nature of death, and what it is about each individual that continues despite great change over time.[5]

Founder of the Extropy Institute, Max More has written many articles espousing the philosophy of transhumanism and the transhumanist philosophy of extropy,[6] most importantly his Principles of Extropy (currently version 3.11).[7][8] In a 1990 essay "Transhumanism: Toward a Futurist Philosophy",[9] he introduced the term "transhumanism" in its modern sense.[10]

More is also noted for his writings about the impact of new and emerging technologies on businesses and other organizations. His "Proactionary Principle" is intended as a balanced guide to the risks and benefits of technological innovation.[11]

At the start of 2011, Max More became president and CEO of the Alcor Life Extension Foundation — the largest provider of cryonics services in the world — an organization he first joined in 1986.[12]

Quotes[edit]

"We have achieved two of the three alchemists' dreams: We have transmuted the elements and learned to fly. Immortality is next." — Max More, On becoming posthuman.

"No more gods, no more faith, no more timid holding back. Let us blast out of our old forms, our ignorance, our weakness, and our mortality. The future belongs to posthumanity." — Max More, On becoming posthuman.

"People’s freedom to innovate technologically is highly valuable, even critical, to humanity. This implies a range of responsibilities for those considering whether and how to develop, deploy, or restrict new technologies. Assess risks and opportunities using an objective, open, and comprehensive, yet simple decision process based on science rather than collective emotional reactions. Account for the costs of restrictions and lost opportunities as fully as direct effects. Favor measures that are proportionate to the probability and magnitude of impacts, and that have the highest payoff relative to their costs. Give a high priority to people’s freedom to learn, innovate, and advance." — Max More, The Proactionary Principle.

See also[edit]

References[edit]

  1. ^ Alex Heard, "Technology Makes us Optimistic; They Want To Live," New York Times, September 28, 1997
  2. ^ Joel Garreau, The Next Generation; Biotechnology May Make Superhero Fantasy a Reality, Washington Post, April 26, 2002.
  3. ^ Regis, Ed. "Meet the Extropians". Wired. 
  4. ^ Hughes, James. "The Politics of Transhumanism". 
  5. ^ More, Max. "The Diachronic Self: Identity, Continuity, Transformation". A. Bell & Howell. 
  6. ^ More, Max. "The Philosophy of Transhumanism". John Wiley & Sons, Oxford. Retrieved 16 May 2013. 
  7. ^ More, Max. "Principles of Extropy". Extropy Institute. Retrieved 16 May 2013. 
  8. ^ Resources for Germline Technology, Washington Post, February 9, 2003.
  9. ^ More, Max. "Transhumanism: Towards a Futurist Philosophy". Retrieved 16 May 2013. 
  10. ^ Bostrom, Nick (April 2005). "A history of transhumanist thought". Journal of Evolution and Technology 14 (1): 1–25. 
  11. ^ More, Max; N. Vita-More (11 March 2003). "The Proactionary Principle". The Transhumanist Reader: Classical and Contemporary Essays on the Science, Technology, and Philosophy of the Human Future. doi:10.1002/9781118555927.ch26. Retrieved 16 May 2013. 
  12. ^ "Alcor Life Extension Foundation Names Max More, PhD, as Chief Executive Officer". Alcor News. Retrieved 16 May 2013. 

External links[edit]